newsfilter
← Latest News
GlobeNewswire·

Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

EXTON, Pa., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), or the Company, announced today that the U.S. Patent and Trademark Office will issue on November 5, 2019...